These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8397797)

  • 1. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system.
    Ohgaki H; Eibl RH; Schwab M; Reichel MB; Mariani L; Gehring M; Petersen I; Höll T; Wiestler OD; Kleihues P
    Mol Carcinog; 1993; 8(2):74-80. PubMed ID: 8397797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
    Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J
    Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing.
    Hunter SB; Bandea C; Swan D; Abbott K; Varma VA
    Mod Pathol; 1993 Jul; 6(4):442-5. PubMed ID: 8415589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
    Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutations in sporadic adrenocortical tumors.
    Ohgaki H; Kleihues P; Heitz PU
    Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC
    Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutations in pediatric brain tumors.
    Felix CA; Slavc I; Dunn M; Strauss EA; Phillips PC; Rorke LB; Sutton L; Bunin GR; Biegel JA
    Med Pediatr Oncol; 1995 Dec; 25(6):431-6. PubMed ID: 7565304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
    Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
    Dahiya R; Deng G; Selph C; Carroll P; Presti J
    Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
    Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and mutation analysis of the p53 gene in astrocytoma.
    Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL
    J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 mutations in malignant astrocytomas.
    Biernat W; Debiec-Rychter M; Kordek R; Liberski PP
    Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type and frequency of p53 mutations in tumors of the nervous system and its coverings.
    Kleihues P; Ohgaki H; Eibl RH; Reichel MB; Mariani L; Gehring M; Petersen I; Höll T; von Deimling A; Wiestler OD
    Recent Results Cancer Res; 1994; 135():25-31. PubMed ID: 8047694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.